Genetic Navigation: A Narrative Review of XRCC1 Polymorphism Impact on Platinum-Based Chemotherapy Outcomes in NSCLC Patients
Lanny Indah Permatasari,1,2 Nadiya Nurul Afifah,1 Maryam Hasymia Ishmatullah,1 Ruri Intania,3 Eli Halimah,2 Melisa Intan Barliana1,4 1Department of Biological Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia; 2Department of Pharmacology and Clinical Pharmacy, Faculty of Ph...
Saved in:
| Main Authors: | Permatasari LI, Afifah NN, Ishmatullah MH, Intania R, Halimah E, Barliana MI |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-02-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/genetic-navigation-a-narrative-review-of-xrcc1-polymorphism-impact-on--peer-reviewed-fulltext-article-CMAR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms
by: Istemi SERIN, et al.
Published: (2021-02-01) -
The Role of ADCY1 in Regulating the Sensitivity of Platinum-Based Chemotherapy in NSCLC
by: Ting Zou, et al.
Published: (2024-08-01) -
A nonsense mutation of human XRCC4 is associated with adult‐onset progressive encephalocardiomyopathy
by: Leonardo Bee, et al.
Published: (2015-04-01) -
RADIOTHERAPY IN MANAGEMENT OF BRCA-POSITIVE OVARIAN CANCER
by: T. V. Gorodnova, et al.
Published: (2017-09-01) -
Predictive Value of Tumor ERCC1 Expression for Treatment Outcomes After Adjuvant Chemotherapy in Patients with Completely Resected Non-Small Cell Lung Cancer
by: Nakata M, et al.
Published: (2025-07-01)